WO2000004005A1 - Derives acides amines et medicaments dont ces derives sont les principes actifs - Google Patents

Derives acides amines et medicaments dont ces derives sont les principes actifs Download PDF

Info

Publication number
WO2000004005A1
WO2000004005A1 PCT/JP1999/003776 JP9903776W WO0004005A1 WO 2000004005 A1 WO2000004005 A1 WO 2000004005A1 JP 9903776 W JP9903776 W JP 9903776W WO 0004005 A1 WO0004005 A1 WO 0004005A1
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
same
active ingredient
acid derivatives
drugs containing
Prior art date
Application number
PCT/JP1999/003776
Other languages
English (en)
French (fr)
Inventor
Takuya Seko
Masashi Kato
Original Assignee
Ono Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co., Ltd. filed Critical Ono Pharmaceutical Co., Ltd.
Priority to EP99929813A priority Critical patent/EP1097929A4/en
Priority to US09/743,393 priority patent/US6903119B1/en
Publication of WO2000004005A1 publication Critical patent/WO2000004005A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/JP1999/003776 1998-07-14 1999-07-13 Derives acides amines et medicaments dont ces derives sont les principes actifs WO2000004005A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99929813A EP1097929A4 (en) 1998-07-14 1999-07-13 AMINO ACID DERIVATIVES AND MEDICAMENTS IN WHICH THESE DERIVATIVES ARE THE ACTIVE INGREDIENTS
US09/743,393 US6903119B1 (en) 1998-07-14 1999-07-13 Amino acid derivatives and drugs containing the same as the active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10/213452 1998-07-14
JP21345298 1998-07-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/892,366 Division US7427634B2 (en) 1998-07-14 2004-07-16 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them

Publications (1)

Publication Number Publication Date
WO2000004005A1 true WO2000004005A1 (fr) 2000-01-27

Family

ID=16639462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/003776 WO2000004005A1 (fr) 1998-07-14 1999-07-13 Derives acides amines et medicaments dont ces derives sont les principes actifs

Country Status (4)

Country Link
US (2) US6903119B1 (ja)
EP (1) EP1097929A4 (ja)
KR (1) KR100633349B1 (ja)
WO (1) WO2000004005A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009106A2 (en) * 1998-08-14 2000-02-24 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
JP2003528854A (ja) * 2000-03-27 2003-09-30 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 医薬として活性なピロリジン誘導体
JP2003529584A (ja) * 2000-03-27 2003-10-07 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ Ｂａｘ阻害剤としての医薬として活性なピロリジン誘導体
WO2004113332A1 (ja) * 2003-06-19 2004-12-29 Ono Pharmaceutical Co., Ltd. 経鼻製剤

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101052065B1 (ko) 2008-10-15 2011-07-27 한국과학기술연구원 칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법
WO2010097374A1 (de) * 2009-02-26 2010-09-02 Boehringer Ingelheim International Gmbh Verbindungen als bradykinin-b1-antagonisten

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61200950A (ja) * 1985-02-15 1986-09-05 リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド アミノ酸誘導体抗痙攣剤
JPH07501085A (ja) * 1992-09-03 1995-02-02 ベーリンガー　インゲルハイム　コマンディトゲゼルシャフト 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物
JPH1095758A (ja) * 1996-05-03 1998-04-14 Lilly Ind Ltd 中枢神経系病の治療剤
WO1999002146A1 (fr) * 1997-07-08 1999-01-21 Ono Pharmaceutical Co., Ltd. Derives d'acide amine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2563743A (en) * 1947-11-07 1951-08-07 Ralph L Evans 1-prolyl-1-cysteinyl-1-tyrosine
NZ219607A (en) 1986-03-14 1990-11-27 Syntex Inc Trans-glutamase inhibitors - oxazole derivatives
US4971978A (en) 1987-09-21 1990-11-20 Nadzan Alex M Derivatives of D-glutamic acid and D-aspartic acid
JPS6483055A (en) * 1987-09-25 1989-03-28 Watanabe Hidehiko Production of peptide and aspartic acid derivative
IL94805A (en) 1989-06-28 1994-04-12 Ciba Geigy Ag Certain translocated carboxylic acids (a) Arylsulfonamide - and pyridyl - or imidazolil (), process for their preparation and pharmaceutical preparations containing them
US5138061A (en) 1989-08-04 1992-08-11 Biochem Pharma Inc. Thioacylating reagents
ATE163290T1 (de) 1991-06-24 1998-03-15 Neurosearch As Imidazol-verbindungen, verfahren zu ihrer herstellung und ihre anwendung
GB9201755D0 (en) 1992-01-28 1992-03-11 British Bio Technology Compounds
JPH0680696A (ja) 1992-09-01 1994-03-22 Mitsubishi Kasei Corp 新規ペプチド
WO1994007815A2 (en) 1992-09-25 1994-04-14 Abbott Laboratories Small peptide anaphylatoxin receptor ligands
EP0673247A4 (en) 1992-12-01 1996-05-01 Merck & Co Inc FIBRINOGEN RECEPTOR ANTAGONISTS.
FR2723739B1 (fr) 1994-08-19 1997-02-14 Sanofi Sa Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
GB9420763D0 (en) 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
JPH08208690A (ja) 1995-02-08 1996-08-13 Sankyo Co Ltd ペプチド化合物
JPH08217671A (ja) 1995-02-15 1996-08-27 Sankyo Co Ltd Ｎ−（３−アシロキシアシル）グリシン誘導体
JPH08217751A (ja) 1995-02-17 1996-08-27 Toubishi Yakuhin Kogyo Kk 抗ｃｃｋ活性を有するセリン、アスパラギン酸及びグルタミン酸誘導体
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
ATE225343T1 (de) 1995-12-20 2002-10-15 Hoffmann La Roche Matrix-metalloprotease inhibitoren
EP0994104A4 (en) 1996-06-27 2001-09-12 Ono Pharmaceutical Co ARYL SULFIDE, SULFOXIDE AND SULPHONE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT
WO1998054123A1 (en) 1997-05-30 1998-12-03 Warner-Lambert Company Substituted peptidylamine calcium channel blockers
KR20010032253A (ko) 1997-11-18 2001-04-16 이타가키 히로시 시클릭 아민 유도체 및 그 약제로서의 용도
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61200950A (ja) * 1985-02-15 1986-09-05 リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド アミノ酸誘導体抗痙攣剤
JPH07501085A (ja) * 1992-09-03 1995-02-02 ベーリンガー　インゲルハイム　コマンディトゲゼルシャフト 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物
JPH1095758A (ja) * 1996-05-03 1998-04-14 Lilly Ind Ltd 中枢神経系病の治療剤
WO1999002146A1 (fr) * 1997-07-08 1999-01-21 Ono Pharmaceutical Co., Ltd. Derives d'acide amine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1097929A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009106A2 (en) * 1998-08-14 2000-02-24 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
WO2000009106A3 (en) * 1998-08-14 2000-10-12 Guilford Pharm Inc Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
JP2003528854A (ja) * 2000-03-27 2003-09-30 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 医薬として活性なピロリジン誘導体
JP2003529584A (ja) * 2000-03-27 2003-10-07 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ Ｂａｘ阻害剤としての医薬として活性なピロリジン誘導体
WO2004113332A1 (ja) * 2003-06-19 2004-12-29 Ono Pharmaceutical Co., Ltd. 経鼻製剤

Also Published As

Publication number Publication date
US7427634B2 (en) 2008-09-23
US6903119B1 (en) 2005-06-07
KR100633349B1 (ko) 2006-10-16
EP1097929A4 (en) 2005-12-21
KR20010083109A (ko) 2001-08-31
EP1097929A1 (en) 2001-05-09
US20050009890A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
NZ508757A (en) Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
WO1999002146A8 (fr) Derives d'acide amine
WO2002067916A3 (de) Pharmazeutische salze
EP1378509A4 (en) DRUGS WITH TRIAZASPIRO ç5.5] UNDECANDERIVATES AS ACTIVE SUBSTANCE
EP0937459A3 (en) Pharmaceutical compositions for the treatment of ischemic brain damage
CA2443724A1 (en) Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
EP2298416A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
WO2004005281A8 (en) Inhibitors of tyrosine kinases
WO2003030937A1 (fr) Remedes contre des maladies liees au stress comprenant des antagonistes de recepteurs mithochondriaux de la benzodiazepine
AU2001275798A1 (en) 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
WO1995009619A3 (en) Substituted urea and isothiourea derivatives as no synthase inhibitors
WO2002102375A3 (fr) Derives d'imidazoles modulant les canaux sodiques
WO2000004005A1 (fr) Derives acides amines et medicaments dont ces derives sont les principes actifs
WO2002018348A3 (en) Quinazoline derivatives as alpha-1 adrenergic antagonists
AU2003293746A1 (en) Crystalline cefdinir salts
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
WO2000078296A3 (en) Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
EP1142881A4 (en) POLY (ADP-RIBOSE) POLYMERASE INHIBITORS CONSISTING OF PYRIMIDINE DERIVATIVES
EP1123923A4 (en) DIHYDROPYRIDINE DERIVATIVES AND DRUG BLOCK CONTAINING THESE
BR0207102A (pt) Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif
EP1193259A4 (en) dihydropyrimidine
BR9901996A (pt) Método de preparação de quinazolin-4-onas substituìdas.
DE69927997D1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
BR0316876A (pt) Compostos de tiazol e composição farmacêutica compreendendo o mesmo

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09743393

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999929813

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020017000534

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1999929813

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020017000534

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 1020017000534

Country of ref document: KR